Last update:

Oncology & Cancer news

Oncology & Cancer

Early blood test can predict survival in men newly diagnosed with metastatic prostate cancer, clinical trial finds

A blood test, performed when metastatic prostate cancer is first diagnosed, can predict which patients are likely to respond to treatment and survive the longest. It can help providers decide which patients should receive ...

Oncology & Cancer

Scientists discover that special immune cells stop metastatic cancer

Metastatic disease—when cancer spreads from the primary tumor to other parts of the body—is the cause of most cancer deaths. While researchers understand how cancer cells escape the primary site to seed new tumors, it's ...

Oncology & Cancer

Study unveils the role of gamma-delta T cells in cancer immunology

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 cancer types, shedding light on their potential as clinical biomarkers and therapeutic targets in cancer ...

Oncology & Cancer

Colonoscopies among the young are on the rise

Colon cancers are increasing among younger Americans, so much so that experts advised in 2021 that colonoscopy screening begins at the age of 45, not 50 as had been previously recommended.

Oncology & Cancer

New imaging technique accurately detects aggressive kidney cancer

A new study led by investigators from the UCLA Health Jonsson Comprehensive Cancer Center has demonstrated a new, non-invasive imaging technique can accurately detect clear-cell renal cell carcinoma, the most common form ...

Oncology & Cancer

Mineralization of bone matrix regulates tumor cell growth

Tumor cells are known to be fickle sleeper agents, often lying dormant in distant tissues for years before reactivating and forming metastasis. Numerous factors have been studied to understand why the activation occurs, from ...

Oncology & Cancer

AI model can help determine where a patient's cancer originated

For a small percentage of cancer patients, doctors are unable to determine where their cancer originated. This makes it much more difficult to choose a treatment for those patients, because many cancer drugs are typically ...

Oncology & Cancer

RNA stability may play a role in prostate cancer

Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center published in Cell Reports.

Oncology & Cancer

New method to identify mutations in childhood brain tumors

Researchers at Uppsala university have developed a new method to find mutations in brain tumors in children. They also showed that the mutations change how cancer cells respond to a cancer drug. These findings could lead ...

Oncology & Cancer

Team develops effective cigar warning signage

A new study published by UNC Family Medicine's Sarah Kowitt, Ph.D., MPH, and colleagues looked at the impact of different types of warning signs for large and premium cigars sold individually at the point of sale. The team's ...

Oncology & Cancer

Team discovers broken 'brake' of cancer mutation machine

Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that creates random mutations throughout the genome that drive resistance to targeted treatments, a team led by UT Southwestern Medical ...

Oncology & Cancer

AGO2 in T-prolymphocytic leukemia (T-PLL)

A new editorial paper titled "AGO2 in T-prolymphocytic leukemia: its canonical and noncanonical deregulation and function" has been published in Oncotarget.

Medications

Common blood thinner may double as cancer therapy

Warfarin, a widely used blood thinner, appears to have potent anti-cancer properties, according to a study by Columbia University researchers. The study, conducted in human cells and in mice, found that warfarin stops tumors ...